Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 7350395)

1.

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin.

Jung JA, Lee SY, Kim TE, Kim JR, Kim C, Huh W, Ko JW.

Drug Des Devel Ther. 2015 Mar 2;9:737-43. doi: 10.2147/DDDT.S76591. eCollection 2015.

2.

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e44S-88S. doi: 10.1378/chest.11-2292. Review.

3.

Considerations when prescribing trimethoprim-sulfamethoxazole.

Ho JM, Juurlink DN.

CMAJ. 2011 Nov 8;183(16):1851-8. doi: 10.1503/cmaj.111152. Epub 2011 Oct 11. Review. No abstract available.

5.

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

Rolan PE.

Br J Clin Pharmacol. 1994 Feb;37(2):125-8. Review. No abstract available.

7.

Stereoselective interaction between the R enantiomer of warfarin and cimetidine.

Choonara IA, Cholerton S, Haynes BP, Breckenridge AM, Park BK.

Br J Clin Pharmacol. 1986 Mar;21(3):271-7.

8.

Cimetidine-nicoumalone interaction in man: stereochemical considerations.

Gill TS, Hopkins KJ, Bottomley J, Gupta SK, Rowland M.

Br J Clin Pharmacol. 1989 Apr;27(4):469-74.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk